Advertisement.
Advertisement.
Advertisement
Advertisement.
QGEN Qiagen NV
1,399
| Market Cap | $9.37B |
| Volume | 1.49M |
| 52-Wk High | $48.80 |
| 52-Wk Low | $35.81 |
Futures Flat As Tech Stocks Rise For 7th Consecutive Day
Zero Hedge•1 month ago
Futures Flat As Tech Stocks Rise For 7th Consecutive Day
Futures are flat with gigatech naturally outperforming into today's retail sales print where the expectations are for beats to...
Share to Feed
Novel QIAcuity dPCR PanCancer Kits can detect rare mutations of EGFR and BRAF genes at the same time, while saving sample material, reducing time and cost // New QIAseq Targeted RNA-seq Panel for...
Globe Newswire•4 months ago
In trading on Monday, shares of Qiagen NV (QGEN) crossed below their 200 day moving average of 42.88, changing hands as low as 42.82 per share. Qiagen NV shares are currently trading down...
Market News Video•4 months ago
QIAstat-Dx Analyzer 2.0 with Software 1.6 release enables mobile access to test results, streamlining diagnostic processes and enhancing patient care // QIAstat-Dx Analyzer 2.0 also offers enhanced...
Globe Newswire•4 months ago
Joint educational initiative to focus on Interferon Gamma Release Assay (IGRA) benefits for healthcare providers // Updated U.S. CDC guidelines mandate IGRA testing for individuals aged 2 and older...
Globe Newswire•4 months ago
Venlo, the Netherlands, March 11, 2024 (GLOBE NEWSWIRE) -- QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today that it has filed its annual report, including its audited...
Globe Newswire•5 months ago
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Qiagen NV (QGEN), where a total volume of 5,610 contracts has been traded thus...
Stock Options Channel•5 months ago
QIAGEN Biomedical KB-AI contains over 640 million biomedical relationships, including gene, disease and drug causal relationships, to aid in data-driven drug discovery // AI-driven insights...
Globe Newswire•5 months ago
Additional ecofriendly QIAwave kits for DNA and RNA extraction receive ACT Label due to greatly improved Environmental Impact Factor compared to standard kits // QIAGEN's Sample technologies R&D lab...
Globe Newswire•5 months ago
Qiagen (NYSE:QGEN Free Report) Investment analysts at Zacks Research reduced their Q2 2024 EPS estimates for shares of Qiagen in a research report issued to clients and investors on...
Zolmax•5 months ago